Statistics for The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
Total visits
| views | |
|---|---|
| The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis | 49 |
Total visits per month
| views | |
|---|---|
| December 2024 | 9 |
| January 2025 | 3 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf | 15 |
| The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf(legacy) | 11 |
Top country views
| views | |
|---|---|
| United States | 15 |
| Portugal | 10 |
| India | 8 |
| China | 6 |
| Brazil | 4 |
| Singapore | 2 |
| Australia | 1 |
| Iraq | 1 |
| South Korea | 1 |
| Mongolia | 1 |
| Mexico | 1 |
| Romania | 1 |
Top city views
| views | |
|---|---|
| Kolkata | 2 |